CoChat
Sign Up
Cited by 1

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Proteomic analysis of the effect of the polyphenol pentagalloyl glucose on proteins involved in neurodegenerative diseases in activated BV‑2 microglial cells

Mendonca, Patricia, Taka, Equar, Soliman, Karam·2019·Molecular Medicine Reports
DOI 10.3892/mmr.2019.10400PMC PMC6625426
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3892/mmr.2019.10400

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 60

  1. Henn, 2009, The suitability of BV-2 cells as an alternative model system for primary microglia cultures for animal experiments examining brain inflammation, ALTEX, 26, 83, 10.14573/altex.2009.2.83 · DOI · Paper page
  2. Gendelman, 2002, Neural immunity: Friend or foe?, J Neurovirol, 8, 474, 10.1080/13550280290168631 · DOI
  3. Oh, 2004, Penta-O-galloyl-Beta-D-glucose inhibits phorbol myristate acetate-induced interleukin-8 [correction of interleukin-8] gene expression in human monocytic U937 cells through its inactivation of nuclear factor-kappa B, Int Immunopharmacol, 4, 377, 10.1016/j.intimp.2003.10.010 · DOI
  4. Gao, 2008, Why neurodegenerative diseases are progressive: Uncontrolled inflammation drives disease progression, Trends Immunol, 29, 357, 10.1016/j.it.2008.05.002 · DOI
  5. Etminan, 2003, Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: Systematic review and meta-analysis of observational studies, BMJ, 327, 128, 10.1136/bmj.327.7407.128 · DOI · Paper page
  6. Heneka, 2011, Molecular mechanisms and therapeutic application of NSAIDs and derived compounds in Alzheimer's disease, Curr Alzheimer Res, 8, 115, 10.2174/156720511795256099 · DOI
  7. Cao, 2014, Biological and biomedical functions of Penta-O-Galloyl-D-Glucose and its derivatives, J Nat Med, 68, 465, 10.1007/s11418-014-0823-2 · DOI
  8. Mendonca, 2017, The attenuating effects of 1,2,3,4,6 Penta-O-Galloyl-β-D-glucose on inflammatory cytokines release from activated BV-2 microglial cells, J Neuroimmunol, 305, 9, 10.1016/j.jneuroim.2017.01.011 · DOI
  9. Mendonca, 2018, The attenuating effects of 1,2,3,4,6 penta-O-galloyl-β-D-glucose on pro-inflammatory responses of LPS/IFNγ-activated BV-2 microglial cells through NFκB and MAPK signaling pathways, J Neuroimmunol, 324, 43, 10.1016/j.jneuroim.2018.09.004 · DOI
  10. Blasi, 1990, Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus, J Neuroimmunol, 27, 229, 10.1016/0165-5728(90)90073-V · DOI
  11. Elsisi, 2005, Ibuprofen and apigenin induce apoptosis and cell cycle arrest in activated microglia, Neurosci Lett, 375, 91, 10.1016/j.neulet.2004.10.087 · DOI
  12. NCBI Resource, 2016, Database resources of the National Center for Biotechnology Information, Nucleic Acids Res, 44, D7, 10.1093/nar/gkv1290 · DOI
  13. Thomas, 2003, PANTHER: A library of protein families and subfamilies indexed by function, Genome Res, 13, 2129, 10.1101/gr.772403 · DOI
  14. Amor, 2014, Inflammation in neurodegenerative diseases-an update, Immunology, 142, 151, 10.1111/imm.12233 · DOI · Paper page
  15. Abdelwahed, 2007, Study of antimutagenic and antioxidant activities of Gallic acid and 1,2,3,4,6 penta galloyl glucose from Pistacia lentiscus. Confirmation by microarray expression profiling, Chem Biol Interact, 165, 1, 10.1016/j.cbi.2006.10.003 · DOI
  16. Kim, 2015, The photoprotective potential of penta-O-galloyl-β-D-glucose by targeting NF-κB and MAPK signaling in UVB radiation-induced human dermal fibroblasts and mouse skin, Mol Cells, 38, 982, 10.14348/molcells.2015.0169 · DOI
  17. Aithal, 2013, Enhancement of propyl gallate yield in a nonaqueous medium using novel cell-associated tannase of Bacillus massiliensis, Prep Biochem Biotechnol, 43, 445, 10.1080/10826068.2012.745873 · DOI
  18. Wang, 2006, Phenolic antioxidants from Chinese toon (fresh young leaves and shoots of Toona sinensis), Food Chemistry, 101, 365, 10.1016/j.foodchem.2006.01.044 · DOI
  19. Fujiwara, 2009, Traditional medicinal herb Paeonia suffruticosa and its active constituent 1,2,3,4,6-Penta-O-Galloyl-Beta-D-Glucopyranose have potent anti-aggregation effects on Alzheimer's amyloid beta proteins in vitro and in vivo, J Neurochem, 109, 1648, 10.1111/j.1471-4159.2009.06069.x · DOI
  20. De Almeida, 2017, 1,2,3,4,6-Penta-O-Galloyl-β-D-glucopyranose binds to the N-terminal metal binding region to inhibit amyloid β-protein oligomer and fibril formation, Int J Mass Spectrom, 420, 24, 10.1016/j.ijms.2016.09.018 · DOI
  21. Kinoshita, 1998, Identification of septins in neurofibrillary tangles in Alzheimer's disease, Am J Pathol, 153, 1551, 10.1016/S0002-9440(10)65743-4 · DOI
  22. Tada, 2007, Role of septin cytoskeleton in spine morphogenesis and dendrite development in neurons, Curr Biol, 17, 1752, 10.1016/j.cub.2007.09.039 · DOI
  23. Walikonis, 2000, Identification of proteins in the postsynaptic density fraction by mass spectrometry, J Neurosci, 20, 4069, 10.1523/JNEUROSCI.20-11-04069.2000 · DOI
  24. Barr, 2004, Abnormalities of presynaptic protein CDCrel-1 in the striatum of rats reared in social isolation: Relevance to neural connectivity in schizophrenia, Eur J Neurosci, 20, 303, 10.1111/j.0953-816X.2004.03457.x · DOI
  25. Ageta-Ishihara, 2013, Chronic overload of SEPT4, a parkin substrate that aggregates in Parkinson's disease, causes behavioral alterations but not neurodegeneration in mice, Mol Brain, 6, 35, 10.1186/1756-6606-6-35 · DOI
  26. Dong, 2003, Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1, Proc Natl Acad Sci USA, 100, 12438, 10.1073/pnas.2132992100 · DOI
  27. Gozal, 2011, Aberrant septin 11 is associated with sporadic frontotemporal lobar degeneration, Mol Neurodegener, 6, 82, 10.1186/1750-1326-6-82 · DOI
  28. Ihara, 2007, Sept4, a component of presynaptic scaffold and Lewy bodies, is required for the suppression of alpha-synuclein neurotoxicity, Neuron, 53, 519, 10.1016/j.neuron.2007.01.019 · DOI
  29. Pissuti Damalio, 2012, Self-assembly of human septin 2 into amyloid filaments, Biochimie, 94, 628, 10.1016/j.biochi.2011.09.014 · DOI
  30. Zhang, 2000, Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1, Proc Natl Acad Sci USA, 97, 13354, 10.1073/pnas.240347797 · DOI · Paper page
  31. Crunkhorn, 2017, Neurodegenerative disorders: Ataxin 2 reduction rescues motor defects, Nat Rev Drug Discov, 16, 384, 10.1038/nrd.2017.104 · DOI
  32. Schmidt, 2013, RNAi: A database for cell-based and in vivo RNAi phenotypes, 2013 update, Nucleic Acids Res, 41, D1021, 10.1093/nar/gks1170 · DOI
  33. Stayton, 1983, Regulation, genetics, and properties of adenylosuccinate synthetase, Curr Top Cell Regul, 22, 103, 10.1016/B978-0-12-152822-5.50008-7 · DOI
  34. Borza, 2003, Variations in the response of mouse isozymes of adenylosuccinate synthetase to inhibitors of physiological relevance, J Biol Chem, 278, 6673, 10.1074/jbc.M210838200 · DOI
  35. Oshchepkova-Nedosekina, 2007, A mathematical model for the adenylosuccinate synthetase reaction involved in purine biosynthesis, Theor Biol Med Model, 4, 11, 10.1186/1742-4682-4-11 · DOI
  36. Nomura, 2014, Biochemical analyses of ppGpp effect on adenylosuccinate synthetases, key enzymes in purine biosynthesis in rice, Biosci Biotechnol Biochem, 78, 1022, 10.1080/09168451.2014.910103 · DOI
  37. Sowell, 2009, Proteomics in animal models of Alzheimer's and Parkinson's diseases, Ageing Res Rev, 8, 1, 10.1016/j.arr.2008.07.003 · DOI
  38. Jin, 2005, Quantitative proteomic analysis of mitochondrial proteins: Relevance to Lewy body formation and Parkinson's disease. Brain Res. Mol, Brain Res, 134, 119
  39. Wan, 2014, The role of Wnt signaling in the development of Alzheimer's disease: A potential therapeutic target?, Biomed Res Int, 2014, 301575, 10.1155/2014/301575 · DOI
  40. Zhang, 2017, Epigenetically upregulated WIPF1 plays a major role in BRAF V600E-promoted papillary thyroid cancer aggressiveness, Oncotarget, 8, 900, 10.18632/oncotarget.13400 · DOI
  41. Pestalozzi, 1997, Prognostic importance of thymidylate synthase expression in early breast cancer, J Clin Oncol, 15, 1923, 10.1200/JCO.1997.15.5.1923 · DOI
  42. Johnston, 1995, Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors, Cancer Res, 55, 1407
  43. Nimmagadda, 2008, The role of DNA synthesis imaging in cancer in the era of targeted therapeutics, Cancer Metastasis Rev, 27, 575, 10.1007/s10555-008-9148-5 · DOI
  44. Ranganathan, 1993, Analysis of Glyoxalase-I from normal and tumor tissue from human colon, Biochim Biophys Acta, 1182, 311, 10.1016/0925-4439(93)90074-B · DOI
  45. Ranganathan, 1995, Glyoxalase I in detoxification: Studies using glyoxalase I transfectant cell line, Biochem J, 309, 127, 10.1042/bj3090127 · DOI
  46. Rulli, 2001, Expression of glyoxalase I and II in normal and breast cancer tissues, Breast Cancer Res Treat, 66, 67, 10.1023/A:1010632919129 · DOI
  47. Jones, 2002, Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer, Proteomics, 2, 76, 10.1002/1615-9861(200201)2:1<76::AID-PROT76>3.0.CO;2-O · DOI
  48. Di Ilio, 1995, Glyoxalase activities in tumor and non-tumor human urogenital tissues, Cancer Lett, 96, 189, 10.1016/0304-3835(95)03928-P · DOI
  49. Davidson, 1999, Glyoxalase I activity in human prostate cancer: A potential marker and importance in chemotherapy, J Urol, 161, 690, 10.1097/00005392-199902000-00101 · DOI
  50. Fonseca-Sánchez, 2012, Breast cancer proteomics reveals a positive correlation between glyoxalase 1 expression and high tumor grade, Int J Oncol, 41, 670, 10.3892/ijo.2012.1478 · DOI
  51. Ledesma, 1995, Tau protein from Alzheimer's disease patients is glycated at its tubulin-binding domain, J Neurochem, 65, 1658, 10.1046/j.1471-4159.1995.65041658.x · DOI · Paper page
  52. Vitek, 1994, Advanced glycation end products contribute to amyloidosis in Alzheimer disease, Proc Natl Acad Sci USA, 91, 4766, 10.1073/pnas.91.11.4766 · DOI · Paper page
  53. Angeloni, 2014, Role of methylglyoxal in Alzheimer's disease, Biomed Res Int, 2014, 238485, 10.1155/2014/238485 · DOI
  54. Al-Balas, 2016, Novel glyoxalase-I inhibitors possessing a ‘zinc-binding feature’ as potential anticancer agents, Drug Des Devel Ther, 10, 2623, 10.2147/DDDT.S110997 · DOI
  55. Thornalley, 1994, Methylglyoxal, glyoxalases and the development of diabetic complications, Amino Acids, 6, 15, 10.1007/BF00808119 · DOI
  56. Chaudhuri, 2016, A Caenorhabditis elegans model elucidates a conserved role for TRPA1-Nrf signaling in reactive α-Dicarbonyl detoxification, Curr Biol, 26, 3014, 10.1016/j.cub.2016.09.024 · DOI
  57. Schulze-Osthoff, 1997, Regulation of NF-kappa B activation by MAP kinase cascades, Immunobiology, 198, 35, 10.1016/S0171-2985(97)80025-3 · DOI
  58. Brand, 2012, The extracellular signal-regulated kinase 3 (mitogen-activated protein kinase 6 [MAPK6])-MAPK-activated protein kinase 5 signaling complex regulates septin function and dendrite morphology, Mol Cell Biol, 32, 2467, 10.1128/MCB.06633-11 · DOI
  59. Shukla, 2017, Ataxin 2-binding protein 1 is a context-specific positive regulator of Notch signaling during neurogenesis in Drosophila melanogaster, Development, 144, 905, 10.1242/dev.140657 · DOI
  60. Shin, 2006, Notch1 augments NF-kappaB activity by facilitating its nuclear retention, EMBO J, 25, 129, 10.1038/sj.emboj.7600902 · DOI

Cited by

Sorted by citations

See all 1

Metadata

Authors
Mendonca, P., Taka, E., & Soliman, K.
Affiliations
College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL 32307, USA
Venue
Molecular Medicine Reports
Publisher
Spandidos Publications
Published
2019-06-19
ISSN
  • 1791-2997
  • 1791-3004
DOI
10.3892/mmr.2019.10400
PMC
PMC6625426
Cited by
1
References
5

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review